🇺🇸 Intravenous albumin in United States

20 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 20

Most-reported reactions

1. Acute Hepatic Failure — 5 reports (25%)
2. Drug Ineffective For Unapproved Indication — 5 reports (25%)
3. Renal Failure Acute — 5 reports (25%)
4. Shock Haemorrhagic — 5 reports (25%)

Source database →

Frequently asked questions

Is Intravenous albumin approved in United States?

Intravenous albumin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Intravenous albumin in United States?

Hamilton Health Sciences Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.